Loading...

ABIONYX Pharma SA

ABNX.PA•EURONEXT
Healthcare
Biotechnology
€1.36
€0.01(0.74%)

ABIONYX Pharma SA (ABNX.PA) Stock Overview

Explore ABIONYX Pharma SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.5/100

Key Financials

Market Cap47.2M
P/E Ratio-10.72
EPS (TTM)$-0.13
ROE-0.52%
Fundamental Analysis

AI Price Forecasts

1 Week$1.28
1 Month$1.27
3 Months$1.24
1 Year Target$1.00

ABNX.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ABIONYX Pharma SA (ABNX.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 79.53, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $1.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.72 and a market capitalization of 47.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;